← Back to BDSX

Biodesix, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 05/08/2026Mar 2026Filed 05/08/2026Sep 2025Filed 03/11/2025Jun 2025Filed 05/08/2026Mar 2025Filed 05/08/2026Sep 2024Filed 03/11/2025Jun 2024Filed 03/11/2025Mar 2024Filed 03/11/2025
$27$26$22$20$18$18$18$15
−$7.3−$7.8−$8.7−$11−$11−$10−$11−$14
−$0.71−$0.81−$1.16−$1.56−$1.52−$1.40−$0.08−$0.14
109.77.57.37.312797

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.